Antimicrobial Resistance: A Problem Without Borders
“In a 1945 interview with the New York Times, penicillin’s discoverer Alexander Fleming anticipated the development of drug-resistant bacterial strains. Indeed, penicillin-resistant strains were first isolated from patients in significant numbers a year later, in 1946.” (IOM, Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies Workshop Summary, 2010)
The Institute of Medicine's 2014 Richard & Hinda Rosenthal Symposium will explore the current and future impact of antimicrobial resistance, implications for our nation’s health and that of the world, and obstacles and successes in the development of solutions and steps to mitigate this global public health challenge.
The event will include a discussion with panelists:
Rima F. Khabbaz, M.D.
Deputy Director for Infectious Diseases
Director, Office of Infectious Diseases
Centers for Disease Control and Prevention
Stuart B. Levy, M.D.
Distinguished Professor of Molecular Biology & Microbiology and of Medicine
Director of the Center for Adaptation Genetics & Drug Resistance
Tufts University School of Medicine
President of the Alliance for the Prudent Use of Antibiotics
Margaret A. Riley, Ph.D.
Professor, Department of Biology
University of Massachusetts Amherst
Brad Spellberg, M.D.
Associate Medical Director for Inpatient Service
Harbor-UCLA Medical Center
Los Angeles Biomedical Research Institute
Harvey V. Fineberg, M.D., Ph.D.
Institute of Medicine